| pubmed-article:8957474 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8957474 | lifeskim:mentions | umls-concept:C0851887 | lld:lifeskim |
| pubmed-article:8957474 | lifeskim:mentions | umls-concept:C0017296 | lld:lifeskim |
| pubmed-article:8957474 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:8957474 | lifeskim:mentions | umls-concept:C0040132 | lld:lifeskim |
| pubmed-article:8957474 | lifeskim:mentions | umls-concept:C0549473 | lld:lifeskim |
| pubmed-article:8957474 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
| pubmed-article:8957474 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
| pubmed-article:8957474 | lifeskim:mentions | umls-concept:C2699007 | lld:lifeskim |
| pubmed-article:8957474 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:8957474 | pubmed:dateCreated | 1997-1-10 | lld:pubmed |
| pubmed-article:8957474 | pubmed:abstractText | Patients with thyroid carcinoma experience excellent long-term survival; however, up to 16% will die of their disease. We have transformed a rat thyroid follicular cell line (FRTL-5) with a gene (TGCT) that mimics a known mutation associated with thyroid neoplasms. These cells form subcutaneous tumors that metastasize to lung in nude mice. | lld:pubmed |
| pubmed-article:8957474 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8957474 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8957474 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8957474 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8957474 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8957474 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8957474 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8957474 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:8957474 | pubmed:issn | 0039-6060 | lld:pubmed |
| pubmed-article:8957474 | pubmed:author | pubmed-author:BishopJ OJO | lld:pubmed |
| pubmed-article:8957474 | pubmed:author | pubmed-author:LevineM AMA | lld:pubmed |
| pubmed-article:8957474 | pubmed:author | pubmed-author:ZeigerM AMA | lld:pubmed |
| pubmed-article:8957474 | pubmed:author | pubmed-author:SajiMM | lld:pubmed |
| pubmed-article:8957474 | pubmed:author | pubmed-author:TakiyamaYY | lld:pubmed |
| pubmed-article:8957474 | pubmed:author | pubmed-author:EllisonA RAR | lld:pubmed |
| pubmed-article:8957474 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8957474 | pubmed:volume | 120 | lld:pubmed |
| pubmed-article:8957474 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8957474 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8957474 | pubmed:pagination | 921-5 | lld:pubmed |
| pubmed-article:8957474 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:meshHeading | pubmed-meshheading:8957474-... | lld:pubmed |
| pubmed-article:8957474 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8957474 | pubmed:articleTitle | Adenoviral infection of thyroid cells: a rationale for gene therapy for metastatic thyroid carcinoma. | lld:pubmed |
| pubmed-article:8957474 | pubmed:affiliation | Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Md., USA. | lld:pubmed |
| pubmed-article:8957474 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8957474 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8957474 | lld:pubmed |
